NCT02045654Unknown不适用
Retrospective Study for Predictive Marker for Decitabine Treament in MDS Patients
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 1
- 试验地点
- 1
- 主要终点
- Response rate
研究概览
简要总结
To assess the efficacy of decitabine and identify predictors for response to decitabine therapy.
详细描述
- Histologically confirmed Myelodysplastic syndrome Diagnosed with MDS (de novo or secondary) based on the World Health Organization (WHO) classifications
- Survival and response Analysis
- Response rate
- Overall survival
- Leukemia free survival
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Histologically confirmed Myelodysplastic syndrome Diagnosed with MDS (de novo or secondary) based on the World Health Organization (WHO) classifications
排除标准
- 未提供
结局指标
主要结局
Response rate
时间窗: 1 year
International Working Group (IWG) response criteria
次要结局
- Overall survival(1 year)
- Leukemia free survival(1 year)
研究者
Jun Ho Jang
Professor
Samsung Medical Center
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Randomized Study of Decitabine in Maintenance Therapy of Acute Myeloid Leukemia (AML)Acute Myelogenous LeukemiaNCT00398983M.D. Anderson Cancer Center50
已完成
不适用
A Study for Dacogen Treatment in Patients With Myelodysplastic SyndromeMyelodysplastic SyndromeNCT01041846Janssen Korea, Ltd., Korea103
终止
2 期
tailOred dRug repurposIng of dEcitabine in KRAS-dependeNt refracTory pAncreaTic cancErPancreatic Adenocarcinoma MetastaticPancreatic Adenocarcinoma RecurrentNCT05360264Luca Cardone7
Unknown
3 期
Decitabine in Combination With Low-dose Cytarabine in Elderly Patients With Acute Myeloid LeukemiaAcute Myeloid Leukemia, AdultNCT02985372Chunyan Ji30
已完成
3 期
An Effectiveness and Safety Study of Decitabine in Patients With Myelodysplastic SyndromeMyelodysplastic SyndromeNCT01751867Xian-Janssen Pharmaceutical Ltd.135